Skip to content

Clinical study on improvement of cogniton in MCI patients with rTMS protocol optimized based on the characteristic spectrum of cortical responses decoded by EEG signals

Clinical study on improvement of cogniton in MCI patients with rTMS protocol optimized based on the characteristic spectrum of cortical responses decoded by EEG signals

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039744
Enrollment
Unknown
Registered
2020-11-07
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment(aMCI)

Interventions

Optimized rTMS group:Optimized rTMS
HF rTMS group :HF rTMS
Sham rTMS group :Sham rTMS

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Right-handed, 50-85 year old Chinese; 2. Voluntary signing of informed consent; 3. Meet the safety standard of TMS treatment; 4. Patients diagnosed with MCI: All subjects underwent a routine clinical physical examination by a physician at the Memory clinic, and complete a full set of neuropsychological tests, including: overall cognitive function assessment (MMSE and MoCA-B), memory function evaluation (Hopkins verbal learning test, Wechsler logical memory test) and executive function evaluation (Trail Making Test A and B), language function evaluation (Boston naming test and Verbal fluency test-vegetables), visuospatial function evaluation (Rey-Osterrieth Complex Figure Test copy and recall), instrumental daily life capability assessment (IADL), clinical dementia rating scale (CDR) evaluation. Finally, the memory outpatient doctor made a diagnosis of whether the patient belongs to MCI combined with the medical history, physical examination, auxiliary examination (including structural MRI), etc. The diagnostic criteria referring to the results of neuropsychological test battery are: 1) a chief complaint of cognitive decline, or cognitive decline as reported by an caregiver; 2) MMSE score, 1SD); (2) more than 2 cognitive domains were impaired with one indicator; (3) IADL has more than one item scored to more than one point.

Exclusion criteria

Exclusion criteria: 1. Have severe visual, hearing, aphasia and other physical diseases and cannot successfully complete the neuropsychological test; 2. Have a history of other neurological or psychiatric disorders (such as dementia, stroke, Parkinson's disease, epilepsy, major depression, etc.), cardiovascular disease, diabetes, thyroid disease, vitamin B12 deficiency, history or evidence of substance abuse; 3. Have contraindications with MRI scanning; 4. Structural MRI indicated lesions such as new lesions or space-occupying lesions.

Design outcomes

Primary

MeasureTime frame
Neuropsychological test battery ;Event related potential (ERP): N2PC, CDA;

Countries

China

Contacts

Public ContactYunxia Li

Department of Neurology, Tongji Hospital

doctorliyunxia@163.com+86 13636370312

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026